"","title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","characteristics_ch1","characteristics_ch1.1","characteristics_ch1.2","treatment_protocol_ch1","molecule_ch1","extract_protocol_ch1","extract_protocol_ch1.1","extract_protocol_ch1.2","taxid_ch1","description","description.1","description.2","data_processing","data_processing.1","data_processing.2","data_processing.3","platform_id","contact_name","contact_email","contact_department","contact_institute","contact_address","contact_city","contact_zip/postal_code","contact_country","data_row_count","instrument_model","library_selection","library_source","library_strategy","relation","relation.1","supplementary_file_1","donor:ch1","material:ch1","treatment:ch1"
"GSM4224377","unprocessed whole milk from donor A","GSM4224377","Public on Dec 19 2019","Dec 18 2019","Dec 19 2019","SRA","1","breast milk","Homo sapiens","material: whole milk","treatment: untreated","donor: A","HPP samples: subjected to HPP in 62.5°C for 30 minutes in Human Milk Pasteurizer S90 Eco (Sterifeed, Medicare Colgate Ltd, England, Cullompton). HoP samples: HoP using U 4000/65 apparatus (Unipress Equipment, Poland, Celestynow). Control samples: untreated. Storage: frozen at -20°C before further processing.","total RNA","Serum/Plasma Advanced Kit (Qiagen), according to manufacturers instructions.","QIAseq miRNA Library Kit (Qiagen), according to manufacturers instructions.","","9606","mirna_count_table.txt","Milk-1A","","Read adapters were trimmed and UMI sequences were extracted by UMI-tools v1.0.0. Maximum 2bp mismatch in a 19bp-long adapter sequence (AACTGTAGGCACCATCAAT) was allowed. Reads with incomplete UMI sequence (<12nt) and shorter than 15bp after trimming were excluded from the downstream analyses.","Trimmed reads were mapped to miRBase v22 mature human miRNA sequences. Prior to mapping, mature miRNA records with identical sequences were collapsed to allow unique mapping. Bowtie2 v2.3.4.1 local alignment with following parameters was used: “-N1 -L9 --norc -k10 --local --score-min L,4,1.3 --mp 4”. Reads mapping to multiple miRNAs with equal scores were excluded. Uniquely mapped reads were deduplicated based on UMI using the “unique"" method in UMI-tools. Next, SAMtools v1.9 idxstats was used to obtain read counts for each miRNA. The counts are in mirna_count_matrix.txt","Genome_build: GRCh38","Supplementary_files_format_and_content: tab delimited matrix of miRBase mapping read counts","GPL18573","Urszula,,Smyczyńska","urszula.smyczynska@umed.lodz.pl","Department of Biostatistics and Translational Medicine","Medical University of Lodz","Mazowiecka 15","Lodz","92-215","Poland","0","Illumina NextSeq 500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13624323","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7409688","NONE","A","whole milk","untreated"
"GSM4224378","unprocessed whole milk from donor B","GSM4224378","Public on Dec 19 2019","Dec 18 2019","Dec 19 2019","SRA","1","breast milk","Homo sapiens","material: whole milk","treatment: untreated","donor: B","HPP samples: subjected to HPP in 62.5°C for 30 minutes in Human Milk Pasteurizer S90 Eco (Sterifeed, Medicare Colgate Ltd, England, Cullompton). HoP samples: HoP using U 4000/65 apparatus (Unipress Equipment, Poland, Celestynow). Control samples: untreated. Storage: frozen at -20°C before further processing.","total RNA","Serum/Plasma Advanced Kit (Qiagen), according to manufacturers instructions.","QIAseq miRNA Library Kit (Qiagen), according to manufacturers instructions.","","9606","excluded from expression analysis due to low miRNA read count","mirna_count_table.txt","Milk-1B","Read adapters were trimmed and UMI sequences were extracted by UMI-tools v1.0.0. Maximum 2bp mismatch in a 19bp-long adapter sequence (AACTGTAGGCACCATCAAT) was allowed. Reads with incomplete UMI sequence (<12nt) and shorter than 15bp after trimming were excluded from the downstream analyses.","Trimmed reads were mapped to miRBase v22 mature human miRNA sequences. Prior to mapping, mature miRNA records with identical sequences were collapsed to allow unique mapping. Bowtie2 v2.3.4.1 local alignment with following parameters was used: “-N1 -L9 --norc -k10 --local --score-min L,4,1.3 --mp 4”. Reads mapping to multiple miRNAs with equal scores were excluded. Uniquely mapped reads were deduplicated based on UMI using the “unique"" method in UMI-tools. Next, SAMtools v1.9 idxstats was used to obtain read counts for each miRNA. The counts are in mirna_count_matrix.txt","Genome_build: GRCh38","Supplementary_files_format_and_content: tab delimited matrix of miRBase mapping read counts","GPL18573","Urszula,,Smyczyńska","urszula.smyczynska@umed.lodz.pl","Department of Biostatistics and Translational Medicine","Medical University of Lodz","Mazowiecka 15","Lodz","92-215","Poland","0","Illumina NextSeq 500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13624322","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7409689","NONE","B","whole milk","untreated"
"GSM4224379","unprocessed whole milk from donor C","GSM4224379","Public on Dec 19 2019","Dec 18 2019","Dec 19 2019","SRA","1","breast milk","Homo sapiens","material: whole milk","treatment: untreated","donor: C","HPP samples: subjected to HPP in 62.5°C for 30 minutes in Human Milk Pasteurizer S90 Eco (Sterifeed, Medicare Colgate Ltd, England, Cullompton). HoP samples: HoP using U 4000/65 apparatus (Unipress Equipment, Poland, Celestynow). Control samples: untreated. Storage: frozen at -20°C before further processing.","total RNA","Serum/Plasma Advanced Kit (Qiagen), according to manufacturers instructions.","QIAseq miRNA Library Kit (Qiagen), according to manufacturers instructions.","","9606","mirna_count_table.txt","Milk-1C","","Read adapters were trimmed and UMI sequences were extracted by UMI-tools v1.0.0. Maximum 2bp mismatch in a 19bp-long adapter sequence (AACTGTAGGCACCATCAAT) was allowed. Reads with incomplete UMI sequence (<12nt) and shorter than 15bp after trimming were excluded from the downstream analyses.","Trimmed reads were mapped to miRBase v22 mature human miRNA sequences. Prior to mapping, mature miRNA records with identical sequences were collapsed to allow unique mapping. Bowtie2 v2.3.4.1 local alignment with following parameters was used: “-N1 -L9 --norc -k10 --local --score-min L,4,1.3 --mp 4”. Reads mapping to multiple miRNAs with equal scores were excluded. Uniquely mapped reads were deduplicated based on UMI using the “unique"" method in UMI-tools. Next, SAMtools v1.9 idxstats was used to obtain read counts for each miRNA. The counts are in mirna_count_matrix.txt","Genome_build: GRCh38","Supplementary_files_format_and_content: tab delimited matrix of miRBase mapping read counts","GPL18573","Urszula,,Smyczyńska","urszula.smyczynska@umed.lodz.pl","Department of Biostatistics and Translational Medicine","Medical University of Lodz","Mazowiecka 15","Lodz","92-215","Poland","0","Illumina NextSeq 500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13624320","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7409690","NONE","C","whole milk","untreated"
"GSM4224380","Holder pasteurized  whole milk from donor A","GSM4224380","Public on Dec 19 2019","Dec 18 2019","Dec 19 2019","SRA","1","breast milk","Homo sapiens","material: whole milk","treatment: HoP","donor: A","HPP samples: subjected to HPP in 62.5°C for 30 minutes in Human Milk Pasteurizer S90 Eco (Sterifeed, Medicare Colgate Ltd, England, Cullompton). HoP samples: HoP using U 4000/65 apparatus (Unipress Equipment, Poland, Celestynow). Control samples: untreated. Storage: frozen at -20°C before further processing.","total RNA","Serum/Plasma Advanced Kit (Qiagen), according to manufacturers instructions.","QIAseq miRNA Library Kit (Qiagen), according to manufacturers instructions.","","9606","excluded from expression analysis due to low miRNA read count","mirna_count_table.txt","Milk-2A","Read adapters were trimmed and UMI sequences were extracted by UMI-tools v1.0.0. Maximum 2bp mismatch in a 19bp-long adapter sequence (AACTGTAGGCACCATCAAT) was allowed. Reads with incomplete UMI sequence (<12nt) and shorter than 15bp after trimming were excluded from the downstream analyses.","Trimmed reads were mapped to miRBase v22 mature human miRNA sequences. Prior to mapping, mature miRNA records with identical sequences were collapsed to allow unique mapping. Bowtie2 v2.3.4.1 local alignment with following parameters was used: “-N1 -L9 --norc -k10 --local --score-min L,4,1.3 --mp 4”. Reads mapping to multiple miRNAs with equal scores were excluded. Uniquely mapped reads were deduplicated based on UMI using the “unique"" method in UMI-tools. Next, SAMtools v1.9 idxstats was used to obtain read counts for each miRNA. The counts are in mirna_count_matrix.txt","Genome_build: GRCh38","Supplementary_files_format_and_content: tab delimited matrix of miRBase mapping read counts","GPL18573","Urszula,,Smyczyńska","urszula.smyczynska@umed.lodz.pl","Department of Biostatistics and Translational Medicine","Medical University of Lodz","Mazowiecka 15","Lodz","92-215","Poland","0","Illumina NextSeq 500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13624319","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7409691","NONE","A","whole milk","HoP"
"GSM4224381","Holder pasteurized  whole milk from donor B","GSM4224381","Public on Dec 19 2019","Dec 18 2019","Dec 19 2019","SRA","1","breast milk","Homo sapiens","material: whole milk","treatment: HoP","donor: B","HPP samples: subjected to HPP in 62.5°C for 30 minutes in Human Milk Pasteurizer S90 Eco (Sterifeed, Medicare Colgate Ltd, England, Cullompton). HoP samples: HoP using U 4000/65 apparatus (Unipress Equipment, Poland, Celestynow). Control samples: untreated. Storage: frozen at -20°C before further processing.","total RNA","Serum/Plasma Advanced Kit (Qiagen), according to manufacturers instructions.","QIAseq miRNA Library Kit (Qiagen), according to manufacturers instructions.","","9606","excluded from expression analysis due to low miRNA read count","mirna_count_table.txt","Milk-2B","Read adapters were trimmed and UMI sequences were extracted by UMI-tools v1.0.0. Maximum 2bp mismatch in a 19bp-long adapter sequence (AACTGTAGGCACCATCAAT) was allowed. Reads with incomplete UMI sequence (<12nt) and shorter than 15bp after trimming were excluded from the downstream analyses.","Trimmed reads were mapped to miRBase v22 mature human miRNA sequences. Prior to mapping, mature miRNA records with identical sequences were collapsed to allow unique mapping. Bowtie2 v2.3.4.1 local alignment with following parameters was used: “-N1 -L9 --norc -k10 --local --score-min L,4,1.3 --mp 4”. Reads mapping to multiple miRNAs with equal scores were excluded. Uniquely mapped reads were deduplicated based on UMI using the “unique"" method in UMI-tools. Next, SAMtools v1.9 idxstats was used to obtain read counts for each miRNA. The counts are in mirna_count_matrix.txt","Genome_build: GRCh38","Supplementary_files_format_and_content: tab delimited matrix of miRBase mapping read counts","GPL18573","Urszula,,Smyczyńska","urszula.smyczynska@umed.lodz.pl","Department of Biostatistics and Translational Medicine","Medical University of Lodz","Mazowiecka 15","Lodz","92-215","Poland","0","Illumina NextSeq 500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13624338","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7409692","NONE","B","whole milk","HoP"
"GSM4224382","Holder pasteurized  whole milk from donor C","GSM4224382","Public on Dec 19 2019","Dec 18 2019","Dec 19 2019","SRA","1","breast milk","Homo sapiens","material: whole milk","treatment: HoP","donor: C","HPP samples: subjected to HPP in 62.5°C for 30 minutes in Human Milk Pasteurizer S90 Eco (Sterifeed, Medicare Colgate Ltd, England, Cullompton). HoP samples: HoP using U 4000/65 apparatus (Unipress Equipment, Poland, Celestynow). Control samples: untreated. Storage: frozen at -20°C before further processing.","total RNA","Serum/Plasma Advanced Kit (Qiagen), according to manufacturers instructions.","QIAseq miRNA Library Kit (Qiagen), according to manufacturers instructions.","","9606","excluded from expression analysis due to low miRNA read count","mirna_count_table.txt","Milk-2C","Read adapters were trimmed and UMI sequences were extracted by UMI-tools v1.0.0. Maximum 2bp mismatch in a 19bp-long adapter sequence (AACTGTAGGCACCATCAAT) was allowed. Reads with incomplete UMI sequence (<12nt) and shorter than 15bp after trimming were excluded from the downstream analyses.","Trimmed reads were mapped to miRBase v22 mature human miRNA sequences. Prior to mapping, mature miRNA records with identical sequences were collapsed to allow unique mapping. Bowtie2 v2.3.4.1 local alignment with following parameters was used: “-N1 -L9 --norc -k10 --local --score-min L,4,1.3 --mp 4”. Reads mapping to multiple miRNAs with equal scores were excluded. Uniquely mapped reads were deduplicated based on UMI using the “unique"" method in UMI-tools. Next, SAMtools v1.9 idxstats was used to obtain read counts for each miRNA. The counts are in mirna_count_matrix.txt","Genome_build: GRCh38","Supplementary_files_format_and_content: tab delimited matrix of miRBase mapping read counts","GPL18573","Urszula,,Smyczyńska","urszula.smyczynska@umed.lodz.pl","Department of Biostatistics and Translational Medicine","Medical University of Lodz","Mazowiecka 15","Lodz","92-215","Poland","0","Illumina NextSeq 500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13624337","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7409693","NONE","C","whole milk","HoP"
"GSM4224383","high-pressure processed whole milk from donor A","GSM4224383","Public on Dec 19 2019","Dec 18 2019","Dec 19 2019","SRA","1","breast milk","Homo sapiens","material: whole milk","treatment: HPP","donor: A","HPP samples: subjected to HPP in 62.5°C for 30 minutes in Human Milk Pasteurizer S90 Eco (Sterifeed, Medicare Colgate Ltd, England, Cullompton). HoP samples: HoP using U 4000/65 apparatus (Unipress Equipment, Poland, Celestynow). Control samples: untreated. Storage: frozen at -20°C before further processing.","total RNA","Serum/Plasma Advanced Kit (Qiagen), according to manufacturers instructions.","QIAseq miRNA Library Kit (Qiagen), according to manufacturers instructions.","","9606","mirna_count_table.txt","Milk-3A","","Read adapters were trimmed and UMI sequences were extracted by UMI-tools v1.0.0. Maximum 2bp mismatch in a 19bp-long adapter sequence (AACTGTAGGCACCATCAAT) was allowed. Reads with incomplete UMI sequence (<12nt) and shorter than 15bp after trimming were excluded from the downstream analyses.","Trimmed reads were mapped to miRBase v22 mature human miRNA sequences. Prior to mapping, mature miRNA records with identical sequences were collapsed to allow unique mapping. Bowtie2 v2.3.4.1 local alignment with following parameters was used: “-N1 -L9 --norc -k10 --local --score-min L,4,1.3 --mp 4”. Reads mapping to multiple miRNAs with equal scores were excluded. Uniquely mapped reads were deduplicated based on UMI using the “unique"" method in UMI-tools. Next, SAMtools v1.9 idxstats was used to obtain read counts for each miRNA. The counts are in mirna_count_matrix.txt","Genome_build: GRCh38","Supplementary_files_format_and_content: tab delimited matrix of miRBase mapping read counts","GPL18573","Urszula,,Smyczyńska","urszula.smyczynska@umed.lodz.pl","Department of Biostatistics and Translational Medicine","Medical University of Lodz","Mazowiecka 15","Lodz","92-215","Poland","0","Illumina NextSeq 500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13624336","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7409694","NONE","A","whole milk","HPP"
"GSM4224384","high-pressure processed whole milk from donor B","GSM4224384","Public on Dec 19 2019","Dec 18 2019","Dec 19 2019","SRA","1","breast milk","Homo sapiens","material: whole milk","treatment: HPP","donor: B","HPP samples: subjected to HPP in 62.5°C for 30 minutes in Human Milk Pasteurizer S90 Eco (Sterifeed, Medicare Colgate Ltd, England, Cullompton). HoP samples: HoP using U 4000/65 apparatus (Unipress Equipment, Poland, Celestynow). Control samples: untreated. Storage: frozen at -20°C before further processing.","total RNA","Serum/Plasma Advanced Kit (Qiagen), according to manufacturers instructions.","QIAseq miRNA Library Kit (Qiagen), according to manufacturers instructions.","","9606","excluded from expression analysis due to low miRNA read count","mirna_count_table.txt","Milk-3B","Read adapters were trimmed and UMI sequences were extracted by UMI-tools v1.0.0. Maximum 2bp mismatch in a 19bp-long adapter sequence (AACTGTAGGCACCATCAAT) was allowed. Reads with incomplete UMI sequence (<12nt) and shorter than 15bp after trimming were excluded from the downstream analyses.","Trimmed reads were mapped to miRBase v22 mature human miRNA sequences. Prior to mapping, mature miRNA records with identical sequences were collapsed to allow unique mapping. Bowtie2 v2.3.4.1 local alignment with following parameters was used: “-N1 -L9 --norc -k10 --local --score-min L,4,1.3 --mp 4”. Reads mapping to multiple miRNAs with equal scores were excluded. Uniquely mapped reads were deduplicated based on UMI using the “unique"" method in UMI-tools. Next, SAMtools v1.9 idxstats was used to obtain read counts for each miRNA. The counts are in mirna_count_matrix.txt","Genome_build: GRCh38","Supplementary_files_format_and_content: tab delimited matrix of miRBase mapping read counts","GPL18573","Urszula,,Smyczyńska","urszula.smyczynska@umed.lodz.pl","Department of Biostatistics and Translational Medicine","Medical University of Lodz","Mazowiecka 15","Lodz","92-215","Poland","0","Illumina NextSeq 500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13624335","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7409695","NONE","B","whole milk","HPP"
"GSM4224385","high-pressure processed  whole milk from donor C","GSM4224385","Public on Dec 19 2019","Dec 18 2019","Dec 19 2019","SRA","1","breast milk","Homo sapiens","material: whole milk","treatment: HPP","donor: C","HPP samples: subjected to HPP in 62.5°C for 30 minutes in Human Milk Pasteurizer S90 Eco (Sterifeed, Medicare Colgate Ltd, England, Cullompton). HoP samples: HoP using U 4000/65 apparatus (Unipress Equipment, Poland, Celestynow). Control samples: untreated. Storage: frozen at -20°C before further processing.","total RNA","Serum/Plasma Advanced Kit (Qiagen), according to manufacturers instructions.","QIAseq miRNA Library Kit (Qiagen), according to manufacturers instructions.","","9606","mirna_count_table.txt","Milk-3C","","Read adapters were trimmed and UMI sequences were extracted by UMI-tools v1.0.0. Maximum 2bp mismatch in a 19bp-long adapter sequence (AACTGTAGGCACCATCAAT) was allowed. Reads with incomplete UMI sequence (<12nt) and shorter than 15bp after trimming were excluded from the downstream analyses.","Trimmed reads were mapped to miRBase v22 mature human miRNA sequences. Prior to mapping, mature miRNA records with identical sequences were collapsed to allow unique mapping. Bowtie2 v2.3.4.1 local alignment with following parameters was used: “-N1 -L9 --norc -k10 --local --score-min L,4,1.3 --mp 4”. Reads mapping to multiple miRNAs with equal scores were excluded. Uniquely mapped reads were deduplicated based on UMI using the “unique"" method in UMI-tools. Next, SAMtools v1.9 idxstats was used to obtain read counts for each miRNA. The counts are in mirna_count_matrix.txt","Genome_build: GRCh38","Supplementary_files_format_and_content: tab delimited matrix of miRBase mapping read counts","GPL18573","Urszula,,Smyczyńska","urszula.smyczynska@umed.lodz.pl","Department of Biostatistics and Translational Medicine","Medical University of Lodz","Mazowiecka 15","Lodz","92-215","Poland","0","Illumina NextSeq 500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13624334","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7409696","NONE","C","whole milk","HPP"
"GSM4224386","unprocessed whole milk from donor A (exosomal fraction)","GSM4224386","Public on Dec 19 2019","Dec 18 2019","Dec 19 2019","SRA","1","breast milk","Homo sapiens","material: exosomes","treatment: untreated","donor: A","HPP samples: subjected to HPP in 62.5°C for 30 minutes in Human Milk Pasteurizer S90 Eco (Sterifeed, Medicare Colgate Ltd, England, Cullompton). HoP samples: HoP using U 4000/65 apparatus (Unipress Equipment, Poland, Celestynow). Control samples: untreated. Storage: frozen at -20°C before further processing.","total RNA","miRCURY Exosome Cell/Urine/CSF Kit (Qiagen, Hilden, Germany), according to manufacturers instructions.","Serum/Plasma Advanced Kit (Qiagen), according to manufacturers instructions.","QIAseq miRNA Library Kit (Qiagen), according to manufacturers instructions.","9606","mirna_count_table.txt","Milk-Ex-1A","","Read adapters were trimmed and UMI sequences were extracted by UMI-tools v1.0.0. Maximum 2bp mismatch in a 19bp-long adapter sequence (AACTGTAGGCACCATCAAT) was allowed. Reads with incomplete UMI sequence (<12nt) and shorter than 15bp after trimming were excluded from the downstream analyses.","Trimmed reads were mapped to miRBase v22 mature human miRNA sequences. Prior to mapping, mature miRNA records with identical sequences were collapsed to allow unique mapping. Bowtie2 v2.3.4.1 local alignment with following parameters was used: “-N1 -L9 --norc -k10 --local --score-min L,4,1.3 --mp 4”. Reads mapping to multiple miRNAs with equal scores were excluded. Uniquely mapped reads were deduplicated based on UMI using the “unique"" method in UMI-tools. Next, SAMtools v1.9 idxstats was used to obtain read counts for each miRNA. The counts are in mirna_count_matrix.txt","Genome_build: GRCh38","Supplementary_files_format_and_content: tab delimited matrix of miRBase mapping read counts","GPL18573","Urszula,,Smyczyńska","urszula.smyczynska@umed.lodz.pl","Department of Biostatistics and Translational Medicine","Medical University of Lodz","Mazowiecka 15","Lodz","92-215","Poland","0","Illumina NextSeq 500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13624333","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7409697","NONE","A","exosomes","untreated"
"GSM4224387","unprocessed whole milk from donor B (exosomal fraction)","GSM4224387","Public on Dec 19 2019","Dec 18 2019","Dec 19 2019","SRA","1","breast milk","Homo sapiens","material: exosomes","treatment: untreated","donor: B","HPP samples: subjected to HPP in 62.5°C for 30 minutes in Human Milk Pasteurizer S90 Eco (Sterifeed, Medicare Colgate Ltd, England, Cullompton). HoP samples: HoP using U 4000/65 apparatus (Unipress Equipment, Poland, Celestynow). Control samples: untreated. Storage: frozen at -20°C before further processing.","total RNA","miRCURY Exosome Cell/Urine/CSF Kit (Qiagen, Hilden, Germany), according to manufacturers instructions.","Serum/Plasma Advanced Kit (Qiagen), according to manufacturers instructions.","QIAseq miRNA Library Kit (Qiagen), according to manufacturers instructions.","9606","mirna_count_table.txt","Milk-Ex-1B","","Read adapters were trimmed and UMI sequences were extracted by UMI-tools v1.0.0. Maximum 2bp mismatch in a 19bp-long adapter sequence (AACTGTAGGCACCATCAAT) was allowed. Reads with incomplete UMI sequence (<12nt) and shorter than 15bp after trimming were excluded from the downstream analyses.","Trimmed reads were mapped to miRBase v22 mature human miRNA sequences. Prior to mapping, mature miRNA records with identical sequences were collapsed to allow unique mapping. Bowtie2 v2.3.4.1 local alignment with following parameters was used: “-N1 -L9 --norc -k10 --local --score-min L,4,1.3 --mp 4”. Reads mapping to multiple miRNAs with equal scores were excluded. Uniquely mapped reads were deduplicated based on UMI using the “unique"" method in UMI-tools. Next, SAMtools v1.9 idxstats was used to obtain read counts for each miRNA. The counts are in mirna_count_matrix.txt","Genome_build: GRCh38","Supplementary_files_format_and_content: tab delimited matrix of miRBase mapping read counts","GPL18573","Urszula,,Smyczyńska","urszula.smyczynska@umed.lodz.pl","Department of Biostatistics and Translational Medicine","Medical University of Lodz","Mazowiecka 15","Lodz","92-215","Poland","0","Illumina NextSeq 500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13624332","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7409698","NONE","B","exosomes","untreated"
"GSM4224388","unprocessed whole milk from donor C (exosomal fraction)","GSM4224388","Public on Dec 19 2019","Dec 18 2019","Dec 19 2019","SRA","1","breast milk","Homo sapiens","material: exosomes","treatment: untreated","donor: C","HPP samples: subjected to HPP in 62.5°C for 30 minutes in Human Milk Pasteurizer S90 Eco (Sterifeed, Medicare Colgate Ltd, England, Cullompton). HoP samples: HoP using U 4000/65 apparatus (Unipress Equipment, Poland, Celestynow). Control samples: untreated. Storage: frozen at -20°C before further processing.","total RNA","miRCURY Exosome Cell/Urine/CSF Kit (Qiagen, Hilden, Germany), according to manufacturers instructions.","Serum/Plasma Advanced Kit (Qiagen), according to manufacturers instructions.","QIAseq miRNA Library Kit (Qiagen), according to manufacturers instructions.","9606","mirna_count_table.txt","Milk-Ex-1C","","Read adapters were trimmed and UMI sequences were extracted by UMI-tools v1.0.0. Maximum 2bp mismatch in a 19bp-long adapter sequence (AACTGTAGGCACCATCAAT) was allowed. Reads with incomplete UMI sequence (<12nt) and shorter than 15bp after trimming were excluded from the downstream analyses.","Trimmed reads were mapped to miRBase v22 mature human miRNA sequences. Prior to mapping, mature miRNA records with identical sequences were collapsed to allow unique mapping. Bowtie2 v2.3.4.1 local alignment with following parameters was used: “-N1 -L9 --norc -k10 --local --score-min L,4,1.3 --mp 4”. Reads mapping to multiple miRNAs with equal scores were excluded. Uniquely mapped reads were deduplicated based on UMI using the “unique"" method in UMI-tools. Next, SAMtools v1.9 idxstats was used to obtain read counts for each miRNA. The counts are in mirna_count_matrix.txt","Genome_build: GRCh38","Supplementary_files_format_and_content: tab delimited matrix of miRBase mapping read counts","GPL18573","Urszula,,Smyczyńska","urszula.smyczynska@umed.lodz.pl","Department of Biostatistics and Translational Medicine","Medical University of Lodz","Mazowiecka 15","Lodz","92-215","Poland","0","Illumina NextSeq 500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13624331","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7409699","NONE","C","exosomes","untreated"
"GSM4224389","Holder pasteurized  whole milk from donor A (exosomal fraction)","GSM4224389","Public on Dec 19 2019","Dec 18 2019","Dec 19 2019","SRA","1","breast milk","Homo sapiens","material: exosomes","treatment: HoP","donor: A","HPP samples: subjected to HPP in 62.5°C for 30 minutes in Human Milk Pasteurizer S90 Eco (Sterifeed, Medicare Colgate Ltd, England, Cullompton). HoP samples: HoP using U 4000/65 apparatus (Unipress Equipment, Poland, Celestynow). Control samples: untreated. Storage: frozen at -20°C before further processing.","total RNA","miRCURY Exosome Cell/Urine/CSF Kit (Qiagen, Hilden, Germany), according to manufacturers instructions.","Serum/Plasma Advanced Kit (Qiagen), according to manufacturers instructions.","QIAseq miRNA Library Kit (Qiagen), according to manufacturers instructions.","9606","excluded from expression analysis due to low miRNA read count","mirna_count_table.txt","Milk-Ex-2A","Read adapters were trimmed and UMI sequences were extracted by UMI-tools v1.0.0. Maximum 2bp mismatch in a 19bp-long adapter sequence (AACTGTAGGCACCATCAAT) was allowed. Reads with incomplete UMI sequence (<12nt) and shorter than 15bp after trimming were excluded from the downstream analyses.","Trimmed reads were mapped to miRBase v22 mature human miRNA sequences. Prior to mapping, mature miRNA records with identical sequences were collapsed to allow unique mapping. Bowtie2 v2.3.4.1 local alignment with following parameters was used: “-N1 -L9 --norc -k10 --local --score-min L,4,1.3 --mp 4”. Reads mapping to multiple miRNAs with equal scores were excluded. Uniquely mapped reads were deduplicated based on UMI using the “unique"" method in UMI-tools. Next, SAMtools v1.9 idxstats was used to obtain read counts for each miRNA. The counts are in mirna_count_matrix.txt","Genome_build: GRCh38","Supplementary_files_format_and_content: tab delimited matrix of miRBase mapping read counts","GPL18573","Urszula,,Smyczyńska","urszula.smyczynska@umed.lodz.pl","Department of Biostatistics and Translational Medicine","Medical University of Lodz","Mazowiecka 15","Lodz","92-215","Poland","0","Illumina NextSeq 500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13624330","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7409700","NONE","A","exosomes","HoP"
"GSM4224390","Holder pasteurized  whole milk from donor B (exosomal fraction)","GSM4224390","Public on Dec 19 2019","Dec 18 2019","Dec 19 2019","SRA","1","breast milk","Homo sapiens","material: exosomes","treatment: HoP","donor: B","HPP samples: subjected to HPP in 62.5°C for 30 minutes in Human Milk Pasteurizer S90 Eco (Sterifeed, Medicare Colgate Ltd, England, Cullompton). HoP samples: HoP using U 4000/65 apparatus (Unipress Equipment, Poland, Celestynow). Control samples: untreated. Storage: frozen at -20°C before further processing.","total RNA","miRCURY Exosome Cell/Urine/CSF Kit (Qiagen, Hilden, Germany), according to manufacturers instructions.","Serum/Plasma Advanced Kit (Qiagen), according to manufacturers instructions.","QIAseq miRNA Library Kit (Qiagen), according to manufacturers instructions.","9606","excluded from expression analysis due to low miRNA read count","mirna_count_table.txt","Milk-Ex-2B","Read adapters were trimmed and UMI sequences were extracted by UMI-tools v1.0.0. Maximum 2bp mismatch in a 19bp-long adapter sequence (AACTGTAGGCACCATCAAT) was allowed. Reads with incomplete UMI sequence (<12nt) and shorter than 15bp after trimming were excluded from the downstream analyses.","Trimmed reads were mapped to miRBase v22 mature human miRNA sequences. Prior to mapping, mature miRNA records with identical sequences were collapsed to allow unique mapping. Bowtie2 v2.3.4.1 local alignment with following parameters was used: “-N1 -L9 --norc -k10 --local --score-min L,4,1.3 --mp 4”. Reads mapping to multiple miRNAs with equal scores were excluded. Uniquely mapped reads were deduplicated based on UMI using the “unique"" method in UMI-tools. Next, SAMtools v1.9 idxstats was used to obtain read counts for each miRNA. The counts are in mirna_count_matrix.txt","Genome_build: GRCh38","Supplementary_files_format_and_content: tab delimited matrix of miRBase mapping read counts","GPL18573","Urszula,,Smyczyńska","urszula.smyczynska@umed.lodz.pl","Department of Biostatistics and Translational Medicine","Medical University of Lodz","Mazowiecka 15","Lodz","92-215","Poland","0","Illumina NextSeq 500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13624329","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7409701","NONE","B","exosomes","HoP"
"GSM4224391","Holder pasteurized  whole milk from donor C (exosomal fraction)","GSM4224391","Public on Dec 19 2019","Dec 18 2019","Dec 19 2019","SRA","1","breast milk","Homo sapiens","material: exosomes","treatment: HoP","donor: C","HPP samples: subjected to HPP in 62.5°C for 30 minutes in Human Milk Pasteurizer S90 Eco (Sterifeed, Medicare Colgate Ltd, England, Cullompton). HoP samples: HoP using U 4000/65 apparatus (Unipress Equipment, Poland, Celestynow). Control samples: untreated. Storage: frozen at -20°C before further processing.","total RNA","miRCURY Exosome Cell/Urine/CSF Kit (Qiagen, Hilden, Germany), according to manufacturers instructions.","Serum/Plasma Advanced Kit (Qiagen), according to manufacturers instructions.","QIAseq miRNA Library Kit (Qiagen), according to manufacturers instructions.","9606","excluded from expression analysis due to low miRNA read count","mirna_count_table.txt","Milk-Ex-2C","Read adapters were trimmed and UMI sequences were extracted by UMI-tools v1.0.0. Maximum 2bp mismatch in a 19bp-long adapter sequence (AACTGTAGGCACCATCAAT) was allowed. Reads with incomplete UMI sequence (<12nt) and shorter than 15bp after trimming were excluded from the downstream analyses.","Trimmed reads were mapped to miRBase v22 mature human miRNA sequences. Prior to mapping, mature miRNA records with identical sequences were collapsed to allow unique mapping. Bowtie2 v2.3.4.1 local alignment with following parameters was used: “-N1 -L9 --norc -k10 --local --score-min L,4,1.3 --mp 4”. Reads mapping to multiple miRNAs with equal scores were excluded. Uniquely mapped reads were deduplicated based on UMI using the “unique"" method in UMI-tools. Next, SAMtools v1.9 idxstats was used to obtain read counts for each miRNA. The counts are in mirna_count_matrix.txt","Genome_build: GRCh38","Supplementary_files_format_and_content: tab delimited matrix of miRBase mapping read counts","GPL18573","Urszula,,Smyczyńska","urszula.smyczynska@umed.lodz.pl","Department of Biostatistics and Translational Medicine","Medical University of Lodz","Mazowiecka 15","Lodz","92-215","Poland","0","Illumina NextSeq 500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13624328","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7409702","NONE","C","exosomes","HoP"
"GSM4224392","high-pressure processed whole milk from donor A (exosomal fraction)","GSM4224392","Public on Dec 19 2019","Dec 18 2019","Dec 19 2019","SRA","1","breast milk","Homo sapiens","material: exosomes","treatment: HPP","donor: A","HPP samples: subjected to HPP in 62.5°C for 30 minutes in Human Milk Pasteurizer S90 Eco (Sterifeed, Medicare Colgate Ltd, England, Cullompton). HoP samples: HoP using U 4000/65 apparatus (Unipress Equipment, Poland, Celestynow). Control samples: untreated. Storage: frozen at -20°C before further processing.","total RNA","miRCURY Exosome Cell/Urine/CSF Kit (Qiagen, Hilden, Germany), according to manufacturers instructions.","Serum/Plasma Advanced Kit (Qiagen), according to manufacturers instructions.","QIAseq miRNA Library Kit (Qiagen), according to manufacturers instructions.","9606","mirna_count_table.txt","Milk-Ex-3A","","Read adapters were trimmed and UMI sequences were extracted by UMI-tools v1.0.0. Maximum 2bp mismatch in a 19bp-long adapter sequence (AACTGTAGGCACCATCAAT) was allowed. Reads with incomplete UMI sequence (<12nt) and shorter than 15bp after trimming were excluded from the downstream analyses.","Trimmed reads were mapped to miRBase v22 mature human miRNA sequences. Prior to mapping, mature miRNA records with identical sequences were collapsed to allow unique mapping. Bowtie2 v2.3.4.1 local alignment with following parameters was used: “-N1 -L9 --norc -k10 --local --score-min L,4,1.3 --mp 4”. Reads mapping to multiple miRNAs with equal scores were excluded. Uniquely mapped reads were deduplicated based on UMI using the “unique"" method in UMI-tools. Next, SAMtools v1.9 idxstats was used to obtain read counts for each miRNA. The counts are in mirna_count_matrix.txt","Genome_build: GRCh38","Supplementary_files_format_and_content: tab delimited matrix of miRBase mapping read counts","GPL18573","Urszula,,Smyczyńska","urszula.smyczynska@umed.lodz.pl","Department of Biostatistics and Translational Medicine","Medical University of Lodz","Mazowiecka 15","Lodz","92-215","Poland","0","Illumina NextSeq 500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13624327","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7409703","NONE","A","exosomes","HPP"
"GSM4224393","high-pressure processed whole milk from donor B (exosomal fraction)","GSM4224393","Public on Dec 19 2019","Dec 18 2019","Dec 19 2019","SRA","1","breast milk","Homo sapiens","material: exosomes","treatment: HPP","donor: B","HPP samples: subjected to HPP in 62.5°C for 30 minutes in Human Milk Pasteurizer S90 Eco (Sterifeed, Medicare Colgate Ltd, England, Cullompton). HoP samples: HoP using U 4000/65 apparatus (Unipress Equipment, Poland, Celestynow). Control samples: untreated. Storage: frozen at -20°C before further processing.","total RNA","miRCURY Exosome Cell/Urine/CSF Kit (Qiagen, Hilden, Germany), according to manufacturers instructions.","Serum/Plasma Advanced Kit (Qiagen), according to manufacturers instructions.","QIAseq miRNA Library Kit (Qiagen), according to manufacturers instructions.","9606","mirna_count_table.txt","Milk-Ex-3B","","Read adapters were trimmed and UMI sequences were extracted by UMI-tools v1.0.0. Maximum 2bp mismatch in a 19bp-long adapter sequence (AACTGTAGGCACCATCAAT) was allowed. Reads with incomplete UMI sequence (<12nt) and shorter than 15bp after trimming were excluded from the downstream analyses.","Trimmed reads were mapped to miRBase v22 mature human miRNA sequences. Prior to mapping, mature miRNA records with identical sequences were collapsed to allow unique mapping. Bowtie2 v2.3.4.1 local alignment with following parameters was used: “-N1 -L9 --norc -k10 --local --score-min L,4,1.3 --mp 4”. Reads mapping to multiple miRNAs with equal scores were excluded. Uniquely mapped reads were deduplicated based on UMI using the “unique"" method in UMI-tools. Next, SAMtools v1.9 idxstats was used to obtain read counts for each miRNA. The counts are in mirna_count_matrix.txt","Genome_build: GRCh38","Supplementary_files_format_and_content: tab delimited matrix of miRBase mapping read counts","GPL18573","Urszula,,Smyczyńska","urszula.smyczynska@umed.lodz.pl","Department of Biostatistics and Translational Medicine","Medical University of Lodz","Mazowiecka 15","Lodz","92-215","Poland","0","Illumina NextSeq 500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13624326","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7409704","NONE","B","exosomes","HPP"
"GSM4224394","high-pressure processed whole milk from donor C (exosomal fraction)","GSM4224394","Public on Dec 19 2019","Dec 18 2019","Dec 19 2019","SRA","1","breast milk","Homo sapiens","material: exosomes","treatment: HPP","donor: C","HPP samples: subjected to HPP in 62.5°C for 30 minutes in Human Milk Pasteurizer S90 Eco (Sterifeed, Medicare Colgate Ltd, England, Cullompton). HoP samples: HoP using U 4000/65 apparatus (Unipress Equipment, Poland, Celestynow). Control samples: untreated. Storage: frozen at -20°C before further processing.","total RNA","miRCURY Exosome Cell/Urine/CSF Kit (Qiagen, Hilden, Germany), according to manufacturers instructions.","Serum/Plasma Advanced Kit (Qiagen), according to manufacturers instructions.","QIAseq miRNA Library Kit (Qiagen), according to manufacturers instructions.","9606","mirna_count_table.txt","Milk-Ex-3C","","Read adapters were trimmed and UMI sequences were extracted by UMI-tools v1.0.0. Maximum 2bp mismatch in a 19bp-long adapter sequence (AACTGTAGGCACCATCAAT) was allowed. Reads with incomplete UMI sequence (<12nt) and shorter than 15bp after trimming were excluded from the downstream analyses.","Trimmed reads were mapped to miRBase v22 mature human miRNA sequences. Prior to mapping, mature miRNA records with identical sequences were collapsed to allow unique mapping. Bowtie2 v2.3.4.1 local alignment with following parameters was used: “-N1 -L9 --norc -k10 --local --score-min L,4,1.3 --mp 4”. Reads mapping to multiple miRNAs with equal scores were excluded. Uniquely mapped reads were deduplicated based on UMI using the “unique"" method in UMI-tools. Next, SAMtools v1.9 idxstats was used to obtain read counts for each miRNA. The counts are in mirna_count_matrix.txt","Genome_build: GRCh38","Supplementary_files_format_and_content: tab delimited matrix of miRBase mapping read counts","GPL18573","Urszula,,Smyczyńska","urszula.smyczynska@umed.lodz.pl","Department of Biostatistics and Translational Medicine","Medical University of Lodz","Mazowiecka 15","Lodz","92-215","Poland","0","Illumina NextSeq 500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13624324","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7409705","NONE","C","exosomes","HPP"
